| Pregnancy prolongation in triplet pregnancies. Oral vs. continuous subcutaneous terbutaline. | |
| | |
MedLine Citation:
|
PMID: 11762154 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To assess gestational gain in triplet pregnancies treated with oral terbutaline followed by treatment with continuous subcutaneous terbutaline. STUDY DESIGN: From a database of patients who received perinatal home care services, we identified women with triplet gestations first receiving daily oral terbutaline following an episode of threatened preterm labor who subsequently received continuous subcutaneous terbutaline infusion after recurrence of preterm contractions. The primary outcome studied was gestational gain with oral terbutaline vs. gestational gain with continuous subcutaneous terbutaline infusion. RESULTS: One hundred four women were studied. The mean gestational age at enrollment was 22.0 +/- 2.7 weeks. Significantly more gestational gain was achieved during subcutaneous tocolytic treatment than during oral treatment (mean 5.4 +/- 3.4 vs. 2.8 +/- 2.2 weeks, P < .001). Twenty-nine percent of desired prolongation was achieved with oral terbutaline, while 71% of desired prolongation was achieved with subcutaneous terbutaline infusion (P < .001). The mean gestational age at delivery was 33.2 +/- 2.2 weeks. CONCLUSION: Gestational gain was greater in triplet pregnancies during treatment with continuous subcutaneous terbutaline infusion than with oral terbutaline. |
| | |
Authors:
|
J P Elliott; N K Bergauer; D L Jacques; S K Coleman; G J Stanziano |
Related Documents
:
|
8910784 - Selective reduction of pregnancy: a legal analysis. 1769814 - Birth of the first 100 babies in hawaii after conception in-vitro: experience at the pa... 8821024 - Multifetal pregnancy reduction and selective termination. 8106944 - A conservative treatment protocol with human menopausal gonadotropins aimed at reducing... 19342014 - Timing of oocyte maturation and egg collection during controlled ovarian stimulation: a... 12743674 - Efficacy, safety and cost of new drugs acting on the central nervous system. |
Publication Detail:
|
Type: Comparative Study; Journal Article |
Journal Detail:
|
Title: The Journal of reproductive medicine Volume: 46 ISSN: 0024-7758 ISO Abbreviation: J Reprod Med Publication Date: 2001 Nov |
Date Detail:
|
Created Date: 2001-12-12 Completed Date: 2002-03-21 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0173343 Medline TA: J Reprod Med Country: United States |
Other Details:
|
Languages: eng Pagination: 975-82 Citation Subset: IM |
Affiliation:
|
Department of Obstetrics and Gynecology, Good Samaritan Medical Center, Phoenix, Arizona, USA. john_elliott@obstetrix.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Oral Adult Female Gestational Age Humans Infusions, Intravenous Obstetric Labor, Premature / prevention & control* Perinatal Care Pregnancy Pregnancy Outcome Retrospective Studies Terbutaline / administration & dosage*, therapeutic use Time Factors Tocolytic Agents / administration & dosage*, therapeutic use Triplets* |
| Chemical | |
Reg. No./Substance:
|
0/Tocolytic Agents; 23031-25-6/Terbutaline |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Urinary profile of endogenous steroids in postmenopausal women with stress urinary incontinence.
Next Document: Medical vs. Surgical treatment of ectopic pregnancy. The University of New Mexico's six-year experie...